https://chinaipr.com/2026/04/03/chinas-asi-strategic-retreat-and-wto-compliance/China IPR - Intellectual Property Developments in Chinaen2026-04-03T21:25:05+00:00China’s ASI Strategic Retreat and WTO Compliancehttps://chinaipr.com/2026/04/02/regifting-signaling-and-implementation-comparing-chinas-ip-commitments-across-the-2026-nte-phase-one-and-the-2016-jcct/China IPR - Intellectual Property Developments in Chinaen2026-04-02T19:08:13+00:00Regifting, Signaling, and Implementation: Comparing China’s IP Commitments Across the 2026 NTE, Phase One, and the 2016 JCCTadministrative enforcement, civil, Eli Lilly, patent linkage, pharmaceutical-ip-protection, NTE Report, supplementation of data, negotiationshttps://chinaipr.com/wp-content/uploads/2026/04/jcct.jpg?w=150